Lucid Capital Markets Starts Quoin Pharmaceuticals (QNRX) at Buy

May 4, 2026 6:08 AM

Lucid Capital Markets analyst Dev Prasad initiates coverage on Quoin Pharmaceuticals ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found